Info
Insider Ownership

Insider Trading & Ownership of Daphne Karydas

Location: Waltham, MA
Summary: The estimated net worth of Daphne Karydas is at least $212,536 dollars as of 20 Feb 2026. Daphne Karydas is the Director of Mineralys Therapeutics, Inc. and owns shares of Mineralys Therapeutics, Inc. (MLYS) stock worth about $212.5K.
Signature: /s/ Adam Levy, Attorney-in-fact
All Insider Reports: All Insider Reports

Notify me when Daphne Karydas files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Daphne Karydas

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
MLYS	Mineralys Therapeutics, Inc.	Director	$212,536	-$689,797	-76%	19 Feb 2026
CMPS	COMPASS Pathways plc	Director				12 Jun 2025
LOGC	LogicBio Therapeutics, Inc.	Director				16 Nov 2022

Insider Transactions Reported by Daphne Karydas:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.